Dr. Keith Crawford, PHEN Director of Clinical Trials and Patient Education provides a brief summary of the prostate cancer crisis with data directly from the American Cancer Society (ACS).

“What’s important for everyone to recognize is that for four years, breast, lung and bronchus and colorectal cancers, the increase in new cases did not exceed four percent, but when you look at prostate cancer for all men in the United States there is a 54% increase. This is alarming,”

– Keith Crawford, MD, PHD, Director of Clinical Trials and Patient Education, PHEN

Key Takeaways:

  • The American Cancer Society predicts that from 2022-2024 that 1 in 6 Black men will develop prostate cancer in their lifetime, compared to 1 in 8 White men. While 1 in 26 Black men will die from prostate cancer, compared to 1 in 44 White men.
  • Even though prostate cancer is known to disproportionately kill black men, academic family physicians are not routinely informing their Black male patients about increased prostate cancer risk.
  • Younger physicians, women and physicians who see less Black male patients are more likely to have suboptimal approach to prostate cancer screening in Black men.
  • The Academic medical community must focus educational efforts on educating family physicians and trainees about facilitating informed decision-making conversations around prostate cancer screening.